{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:03:51Z","timestamp":1793279031401,"version":"4.5.0"},"reference-count":64,"publisher":"The Company of Biologists","issue":"6","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"crossref","award":["IG 2018-ID. 21332"],"award-info":[{"award-number":["IG 2018-ID. 21332"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"crossref","award":["5 per mille #2119"],"award-info":[{"award-number":["5 per mille #2119"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"crossref","award":["IG 2023-ID. 28750"],"award-info":[{"award-number":["IG 2023-ID. 28750"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008594","name":"European Hematology Association","doi-asserted-by":"crossref","award":["2020"],"award-info":[{"award-number":["2020"]}],"id":[{"id":"10.13039\/100008594","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"crossref","award":["PNRR-MCNT2-2023-12378474"],"award-info":[{"award-number":["PNRR-MCNT2-2023-12378474"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ospedale San Raffaele"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Chronic lymphocytic leukaemia (CLL) cells circulate between the blood, bone marrow (BM) and lymphoid organs, where interactions with the lymph node (LN) microenvironment enhance their survival, proliferation and drug resistance. Most in vitro models fail to reproduce the spatial and cellular complexity of the LN niche, limiting studies of tissue-specific drug responses. To address this, we developed a 3D LN model using a gelatine scaffold and a clinorotator bioreactor previously validated for a BM system. The scaffold was seeded with human lymphatic fibroblasts and endothelial cells, which deposited extracellular matrix and supported patient-derived CLL cell viability and proliferation. Consistent with in vivo observations, CLL cells within the scaffold downregulated the chemokine receptor CXCR4, further reduced upon proliferative stimulation. Final validation involved treatment with targeted therapies: the BCL-2 antagonist venetoclax and the BTK inhibitor ibrutinib. Venetoclax treatment revealed greater CLL protection within the LN environment than in BM, whereas the mobilizing effect of ibrutinib was comparable between these two niches. This 3D LN model offers an effective ex vivo platform for studying microenvironment\u2013tumour interactions and tissue-specific drug responses.<\/jats:p>","DOI":"10.1242\/dmm.052731","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T11:27:40Z","timestamp":1770377260000},"source":"Crossref","is-referenced-by-count":6,"title":["A 3D lymph node model for chronic lymphocytic leukaemia recapitulates microenvironmental features and drug response\n                    <i>in vitro<\/i>"],"prefix":"10.1242","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3487-4203","authenticated-orcid":false,"given":"Daniela","family":"Belloni","sequence":"first","affiliation":[{"name":"IRCCS Ospedale San Raffaele, Comprehensive Cancer Center 1 Unit of Malignant B Cells Biology and 3D Modelling, Division of Experimental Oncology , , 20132 Milan ,","place":["Italy"]},{"name":"IRCCS Ospedale San Raffaele, Comprehensive Cancer Center 2 Unit B Cell Neoplasia, Division of Experimental Oncology , , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafne","family":"Barozzi","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale San Raffaele, Comprehensive Cancer Center 1 Unit of Malignant B Cells Biology and 3D Modelling, Division of Experimental Oncology , , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Milani","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale San Raffaele, Comprehensive Cancer Center 2 Unit B Cell Neoplasia, Division of Experimental Oncology , , 20132 Milan ,","place":["Italy"]},{"name":"Medical School, Universit\u00e0 Vita-Salute San Raffaele 3 , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Barbaglio","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale San Raffaele, Comprehensive Cancer Center 1 Unit of Malignant B Cells Biology and 3D Modelling, Division of Experimental Oncology , , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin Raj","family":"Puthukkunnath","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale San Raffaele, Comprehensive Cancer Center 2 Unit B Cell Neoplasia, Division of Experimental Oncology , , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Ranghetti","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale San Raffaele, Comprehensive Cancer Center 2 Unit B Cell Neoplasia, Division of Experimental Oncology , , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Perotta","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale San Raffaele, Comprehensive Cancer Center 2 Unit B Cell Neoplasia, Division of Experimental Oncology , , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Musco","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale San Raffaele, Comprehensive Cancer Center 2 Unit B Cell Neoplasia, Division of Experimental Oncology , , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sampietro","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale San Raffaele, Comprehensive Cancer Center 1 Unit of Malignant B Cells Biology and 3D Modelling, Division of Experimental Oncology , , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale San Raffaele 5 Pathology Unit , , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Scarf\u00f2","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale San Raffaele, Comprehensive Cancer Center 2 Unit B Cell Neoplasia, Division of Experimental Oncology , , 20132 Milan ,","place":["Italy"]},{"name":"Medical School, Universit\u00e0 Vita-Salute San Raffaele 3 , 20132 Milan ,","place":["Italy"]},{"name":"Strategic Research Program on CLL, IRCCS Ospedale San Raffaele 4 , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ghia","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale San Raffaele, Comprehensive Cancer Center 2 Unit B Cell Neoplasia, Division of Experimental Oncology , , 20132 Milan ,","place":["Italy"]},{"name":"Medical School, Universit\u00e0 Vita-Salute San Raffaele 3 , 20132 Milan ,","place":["Italy"]},{"name":"Strategic Research Program on CLL, IRCCS Ospedale San Raffaele 4 , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7988-2824","authenticated-orcid":false,"given":"Cristina","family":"Scielzo","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale San Raffaele, Comprehensive Cancer Center 1 Unit of Malignant B Cells Biology and 3D Modelling, Division of Experimental Oncology , , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"2026061608465125900_DMM052731C1","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"key":"2026061608465125900_DMM052731C2","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1182\/blood-2016-01-688796","article-title":"The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism","volume":"127","author":"Anderson","year":"2016","journal-title":"Blood"},{"key":"2026061608465125900_DMM052731C3","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3390\/cancers16050980","article-title":"Venetoclax initiation in chronic lymphocytic leukemia: international insights and innovative approaches for optimal patient care","volume":"16","author":"Anderson","year":"2024","journal-title":"Cancers"},{"key":"2026061608465125900_DMM052731C4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/ahe.12052","article-title":"Angiogenesis and collagen type IV expression in different endothelial cell culture systems","volume":"43","author":"Bahramsoltani","year":"2014","journal-title":"Anat. Histol. Embryol."},{"key":"2026061608465125900_DMM052731C5","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.3324\/haematol.2020.248112","article-title":"Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents","volume":"106","author":"Barbaglio","year":"2021","journal-title":"Haematologica"},{"key":"2026061608465125900_DMM052731C6","doi-asserted-by":"publisher","first-page":"E932","DOI":"10.1097\/HS9.0000000000000932","article-title":"Emerging strategies in 3D culture models for hematological cancers","volume":"7","author":"Barozzi","year":"2023","journal-title":"Hemasphere"},{"key":"2026061608465125900_DMM052731C7","doi-asserted-by":"publisher","first-page":"101105","DOI":"10.1016\/j.crmeth.2025.101105","article-title":"Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro","volume":"5","author":"Barozzi","year":"2025","journal-title":"Cell Rep. Methods"},{"key":"2026061608465125900_DMM052731C8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3324\/haematol.2017.167486","article-title":"Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3d surrogate microenvironment","volume":"103","author":"Belloni","year":"2018","journal-title":"Haematologica"},{"key":"2026061608465125900_DMM052731C9","doi-asserted-by":"publisher","first-page":"101601","DOI":"10.1016\/j.xpro.2022.101601","article-title":"Protocol for generation of 3D bone marrow surrogate microenvironments in a rotary cell culture system","volume":"3","author":"Belloni","year":"2022","journal-title":"STAR Protoc."},{"key":"2026061608465125900_DMM052731C10","doi-asserted-by":"publisher","first-page":"1376660","DOI":"10.3389\/fimmu.2024.1376660","article-title":"Mouse models of chronic lymphocytic leukemia and Richter transformation: what we have learnt and what we are missing","volume":"15","author":"Bertilaccio","year":"2024","journal-title":"Front. Immunol."},{"key":"2026061608465125900_DMM052731C11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00277-013-1967-y","article-title":"The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia","volume":"93","author":"Brachtl","year":"2014","journal-title":"Ann. Hematol"},{"key":"2026061608465125900_DMM052731C12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1182\/asheducation-2011.1.96","article-title":"Nurture versus nature: the microenvironment in chronic lymphocytic leukemia","volume-title":"Hematology Am. Soc. Hematol. Educ. Program.","author":"Burger","year":"2011"},{"key":"2026061608465125900_DMM052731C13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41571-018-0037-8","article-title":"Evolution of CLL treatment \u2014 from chemoimmunotherapy to targeted and individualized therapy","volume":"15","author":"Burger","year":"2018","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"2026061608465125900_DMM052731C14","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Burger","year":"2000","journal-title":"Blood"},{"key":"2026061608465125900_DMM052731C15","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: a target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"2026061608465125900_DMM052731C16","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1182\/blood-2014-04-565408","article-title":"Anergy: the CLL cell limbo","volume":"123","author":"Caligaris-Cappio","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"2026061608465125900_DMM052731C17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1200\/JCO.1999.17.1.399","article-title":"B-cell chronic lymphocytic leukemia: a bird of a different feather","volume":"17","author":"Caligaris-Cappio","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"2026061608465125900_DMM052731C18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcancer.2013.06.010","article-title":"How the microenvironment wires the natural history of chronic lymphocytic leukemia","volume":"24","author":"Caligaris-Cappio","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"2026061608465125900_DMM052731C19","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.2119\/molmed.2011.00360","article-title":"Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born\/divided and older\/quiescent cells","volume":"17","author":"Calissano","year":"2011","journal-title":"Mol. Med."},{"key":"2026061608465125900_DMM052731C20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/hon.3144","article-title":"Functional consequences of inhibition of Bruton's tyrosine kinase by ibrutinib in chronic lymphocytic leukemia","volume":"41","author":"Chen","year":"2023","journal-title":"Hematol. Oncol."},{"key":"2026061608465125900_DMM052731C21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1053\/j.seminhematol.2014.05.002","article-title":"Microenvironmental interactions in chronic lymphocytic leukemia: the master role of CD49d","volume":"51","author":"Dal Bo","year":"2014","journal-title":"Semin. Hematol."},{"key":"2026061608465125900_DMM052731C22","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1517\/13543776.2014.915942","article-title":"Anti-CD44 mAb for the treatment of B-cell chronic lymphocytic leukemia and other hematological malignancies: evaluation of WO2013063498","volume":"24","author":"D'Arena","year":"2014","journal-title":"Expert. Opin. Ther. Pat."},{"key":"2026061608465125900_DMM052731C23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/sj.leu.2401275","article-title":"Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax, Leukemia","volume":"13","author":"De","year":"1999","journal-title":"Leukemia"},{"key":"2026061608465125900_DMM052731C24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2119\/molmed.2009.00146","article-title":"CD38\/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells","volume":"16","author":"Deaglio","year":"2010","journal-title":"Mol. Med."},{"key":"2026061608465125900_DMM052731C25","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3389\/fonc.2020.01422","article-title":"Importance of crosstalk between chronic lymphocytic leukemia cells and the stromal microenvironment: direct contact, soluble factors, and extracellular vesicles","volume":"10","author":"Dubois","year":"2020","journal-title":"Front. Oncol."},{"key":"2026061608465125900_DMM052731C26","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1056\/nejmoa2213093","article-title":"First-line venetoclax combinations in chronic lymphocytic leukemia","volume":"388","author":"Eichhorst","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"2026061608465125900_DMM052731C27","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00262-021-03043-x","article-title":"Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype","volume":"71","author":"Elias","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"2026061608465125900_DMM052731C28","doi-asserted-by":"publisher","first-page":"e70064","DOI":"10.1002\/hem3.70064","article-title":"Proliferating CLL cells express high levels of CXCR4 and CD5","volume":"8","author":"Friedman","year":"2024","journal-title":"Hemasphere"},{"key":"2026061608465125900_DMM052731C29","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1038\/leu.2016.261","article-title":"B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia","volume":"30","author":"Galletti","year":"2016","journal-title":"Leukemia"},{"key":"2026061608465125900_DMM052731C30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1158\/0008-5472.CAN-12-2749","article-title":"CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility","volume":"73","author":"Girbl","year":"2013","journal-title":"Cancer Res."},{"key":"2026061608465125900_DMM052731C31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ajh.27546","article-title":"Chronic lymphocytic leukemia: 2025 update on the epidemiology, pathogenesis, diagnosis, and therapy","volume":"100","author":"Hallek","year":"2025","journal-title":"Am. J. Hematol."},{"key":"2026061608465125900_DMM052731C32","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"Special report iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"2026061608465125900_DMM052731C33","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1182\/blood.2019004326","article-title":"Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL","volume":"136","author":"Haselager","year":"2020","journal-title":"Blood"},{"key":"2026061608465125900_DMM052731C34","doi-asserted-by":"publisher","first-page":"E938","DOI":"10.1097\/HS9.0000000000000938","article-title":"In vitro 3D spheroid culture system displays sustained T cell-dependent CLL proliferation and survival","volume":"7","author":"Haselager","year":"2023","journal-title":"Hemasphere"},{"key":"2026061608465125900_DMM052731C35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1182\/blood-2010-05","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-B activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"2026061608465125900_DMM052731C64","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3109\/10428194.2011.569962","article-title":"Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1","volume":"52","author":"Herishanu","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"2026061608465125900_DMM052731C36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.hoc.2013.01.002","article-title":"Biology of chronic lymphocytic leukemia in different microenvironments. Clinical and therapeutic implications","volume":"27","author":"Herishanu","year":"2013","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"2026061608465125900_DMM052731C37","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1038\/leu.2014.122","article-title":"Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study","volume":"28","author":"Herman","year":"2014","journal-title":"Leukemia"},{"key":"2026061608465125900_DMM052731C38","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/leu.2017.11","article-title":"Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood","volume":"31","author":"Herndon","year":"2017","journal-title":"Leukemia"},{"key":"2026061608465125900_DMM052731C39","doi-asserted-by":"publisher","first-page":"EVIDoa2200006","DOI":"10.1056\/evidoa2200006","article-title":"Fixed-duration ibrutinib-venetoclax in patients with chronic lymphocytic leukemia and comorbidities","volume":"1","author":"Kater","year":"2022","journal-title":"NEJM Evidence"},{"key":"2026061608465125900_DMM052731C40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/978-3-031-06566-8_17","article-title":"PI3K targeting in non-solid cancer","volume":"436","author":"Kim","year":"2022","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"2026061608465125900_DMM052731C41","doi-asserted-by":"publisher","first-page":"16096","DOI":"10.1038\/nrdp.2016.96","article-title":"Chronic lymphocytic leukaemia","volume":"3","author":"Kipps","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2026061608465125900_DMM052731C42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00214379","article-title":"Basement-membrane components associated with the extracellular matrix of the lymph node","volume":"252","author":"Kramer","year":"1988","journal-title":"Cell Tissue Res."},{"key":"2026061608465125900_DMM052731C43","doi-asserted-by":"publisher","first-page":"e70170","DOI":"10.1002\/hem3.70170","article-title":"A spheroid model that recapitulates the protective role of the lymph node microenvironment and serves as a platform for drug testing in chronic lymphocytic leukemia","volume":"9","author":"Lenti","year":"2025","journal-title":"Hemasphere"},{"key":"2026061608465125900_DMM052731C44","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.3390\/cancers15194706","article-title":"Characterization of the intraclonal complexity of chronic lymphocytic leukemia B cells: potential influences of B-cell receptor crosstalk with other stimuli","volume":"15","author":"Mazzarello","year":"2023","journal-title":"Cancers"},{"key":"2026061608465125900_DMM052731C45","doi-asserted-by":"publisher","first-page":"15746","DOI":"10.1038\/ncomms15746","article-title":"Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia","volume":"8","author":"Minici","year":"2017","journal-title":"Nat. Commun."},{"key":"2026061608465125900_DMM052731C46","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1172\/JCI119129","article-title":"Perspectives series: cell adhesion in vascular biology the biology of PECAM-1","volume":"99","author":"Newman","year":"1997","journal-title":"J. Clin. Invest"},{"key":"2026061608465125900_DMM052731C47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.semcancer.2016.07.001","article-title":"Toll-like receptors signaling: a complex network for NF-\u03baB activation in B-cell lymphoid malignancies","volume":"39","author":"Ntoufa","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"2026061608465125900_DMM052731C48","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1182\/blood-2016-01-683128","article-title":"Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration","volume":"128","author":"Pasikowska","year":"2016","journal-title":"Blood"},{"key":"2026061608465125900_DMM052731C49","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.addr.2020.09.005","article-title":"Fibronectin in development and wound healing","volume":"170","author":"Patten","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2026061608465125900_DMM052731C50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1053\/j.semdp.2011.02.014","article-title":"Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment","volume":"28","author":"Ponzoni","year":"2011","journal-title":"Semin. Diagn. Pathol."},{"key":"2026061608465125900_DMM052731C51","doi-asserted-by":"publisher","first-page":"26019","DOI":"10.18632\/oncotarget.25419","article-title":"A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia","volume":"9","author":"Primo","year":"2018","journal-title":"Oncotarget"},{"key":"2026061608465125900_DMM052731C52","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1038\/s41375-020-0873-2","article-title":"T-cells in chronic lymphocytic leukemia: guardians or drivers of disease?","volume":"34","author":"Roessner","year":"2020","journal-title":"Leukemia"},{"key":"2026061608465125900_DMM052731C53","doi-asserted-by":"publisher","first-page":"110179","DOI":"10.1016\/j.isci.2024.110179","article-title":"Human lymph node fibroblastic reticular cells maintain heterogeneous characteristics in culture","volume":"27","author":"Roet","year":"2024","journal-title":"iScience"},{"key":"2026061608465125900_DMM052731C54","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1002\/1873-3468.70071","article-title":"B cell mechanobiology in health and disease: emerging techniques and insights into therapeutic responses","volume":"599","author":"Sampietro","year":"2025","journal-title":"FEBS Lett."},{"key":"2026061608465125900_DMM052731C55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.critrevonc.2016.06.003","article-title":"Chronic lymphocytic leukaemia","volume":"104","author":"Scarf\u00f2","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"2026061608465125900_DMM052731C56","doi-asserted-by":"publisher","first-page":"607608","DOI":"10.3389\/fonc.2020.607608","article-title":"Modeling the leukemia microenviroment in vitro","volume":"10","author":"Scielzo","year":"2020","journal-title":"Front. Oncol."},{"key":"2026061608465125900_DMM052731C57","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1182\/BLOODADVANCES.2020003423","article-title":"Overcoming resistance to targeted therapies in chronic lymphocytic leukemia","volume":"5","author":"Skanland","year":"2021","journal-title":"Blood Adv"},{"key":"2026061608465125900_DMM052731C58","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/0284186X.2021.1878388","article-title":"Identification of a novel resistance mechanism in venetoclax treatment and its prediction in chronic lymphocytic leukemia","volume":"60","author":"Tak\u00e1cs","year":"2021","journal-title":"Acta Oncol."},{"key":"2026061608465125900_DMM052731C59","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.pharmthera.2014.07.003","article-title":"Microenvironment dependency in Chronic Lymphocytic Leukemia: the basis for new targeted therapies","volume":"144","author":"Ten Hacken","year":"2014","journal-title":"Pharmacol. Ther"},{"key":"2026061608465125900_DMM052731C60","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41375-018-0303-x","article-title":"The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia","volume":"33","author":"ten Hacken","year":"2019","journal-title":"Leukemia"},{"key":"2026061608465125900_DMM052731C61","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1182\/blood.2020006343","article-title":"CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"key":"2026061608465125900_DMM052731C62","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00418-015-1398-z","article-title":"Induction of initial steps of angiogenic differentiation and maturation of endothelial cells by pericytes in vitro and the role of collagen IV","volume":"145","author":"Zhou","year":"2016","journal-title":"Histochem. Cell Biol."},{"key":"2026061608465125900_DMM052731C63","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.17219\/acem\/181145","article-title":"Mechanisms of resistance to venetoclax in hematologic malignancies","volume":"33","author":"Zielonka","year":"2024","journal-title":"Adv. Clin. Exp. Med"}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.052731\/3684049\/dmm052731.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.052731\/3692719\/dmm052731.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.052731\/3692719\/dmm052731.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:46:57Z","timestamp":1781614017000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/19\/6\/dmm052731\/371216\/A-3D-lymph-node-model-for-chronic-lymphocytic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1242\/dmm.052731","relation":{},"ISSN":["1754-8403","1754-8411"],"issn-type":[{"value":"1754-8403","type":"print"},{"value":"1754-8411","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"article-number":"dmm052731"}}